Techno Research

  The global  telehealth market  size is expected to reach USD 787.4 billion by 2028, registering a CAGR of 36.5% over the forecast period, according to a new report by Grand View Research, Inc. The development and evolution of smartphones and the strengthening of internet connectivity have made telehealth and telemedicine more affordable and accessible, and thereby contributed to its growing adoption rate. Advancements in digital infrastructure are allowing users to seamlessly monitor their health & fitness, book appointments, and avail themselves of medical assistance conveniently. For instance, several platforms and applications, such as Doctor on Demand, MDLive, and Lemonaid, are available for booking appointments, monitoring personal health, honoring medical prescriptions, tracking consultations, and storing healthcare information. Due to the COVID-19 pandemic, providers and patients are readily adopting teleconsultation and telemedicine services. The ongoing pandemic exposed

  The global  artificial intelligence in healthcare market  size is expected to reach USD 208.2 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 38.4% from 2022 to 2030. The growing demand for personalized medicine, rising demand for value-based care, growing datasets of patient health-related digital information, advancements in healthcare IT infrastructure, penetration of smartphones, improved internet connectivity, and shortage of care providers is propelling the growth of the market over the forthcoming years. In addition, changing lifestyles, the growing geriatric population, rising prevalence of chronic diseases have contributed to the need for faster and accurate disease detection and improving the understanding of the disease in the early stage, thereby driving the adoption of technologies based on Artificial Intelligence (AI) in healthcare. The ongoing Covid-19 pandemic positively impacted the adoption of AI-

  The  U.S. telehealth market  size is expected to reach USD 307.7 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 44.4% from 2022 to 2028. The increasing adoption of digital health services, favorable consumer base, and substantial investment are the major factors contributing to the market growth in the U.S. Besides, growing demand for remote patient monitoring, coupled with the advancement of digital communication technology to support and improve healthcare services, is anticipated to accelerate the market growth over the forecast years. The shortage of physicians and clinicians in the U.S. is also expected to propel the telehealth industry growth. For instance, according to the Association of American Medical Colleges report published in June 2021, the estimated shortage of physicians in the U.S. could be between 37,800 and 124,000 by 2034, in both specialty and primary care. Increasing remote patient visits using digit

 The global  agrochemicals market  size is expected to reach USD 289.5 billion by 2030, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 3.2% during the forecast period. This increase can be attributed to the need for fertilizers and awareness of insecticides and fertilizers among consumers.  Rapid industrialization and population growth have reduced the amount of arable land available, which has led to an increase in the use of agrochemicals such as fertilizers and plant growth regulators which has further fueled the market expansion. The agrochemicals sector has also benefited from the rising demand for crops needed in the role of animal feed and fiber in the textile industry. In 2021, fertilizers dominated the market for agrochemicals. Due to their low cost and simple availability, phosphate and nitrogen fertilizers were most frequently used. The demand for biofertilizers has increased due to the recent trend of organic farming, which com

  The global  medical specimen tracking system market  size is anticipated to reach USD 1.77 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at a lucrative CAGR of 10.3% from 2022 to 2030. The key factors driving the market growth include the technological advancements by market players and increasing product adoption for reducing errors in patient diagnosis. Before the COVID-19 pandemic, the adoption of specimen tracking solutions was less. However, due to the pandemic, the demand for these systems skyrocketed, which positively influenced the market growth. Most market players, such as Labcorp Drug Development, Agilent Technologies, and Thermo Fisher Scientific, experienced positive growth from 2019 to 2020 in their segment-specific revenues as well as annual revenues. For instance, Labcorp Drug Development experienced 21% growth and Thermo Fisher Scientific experienced 26.1% growth from 2019 to 2020. On the other hand, Zebra Tech

 The global  omics-based clinical trials market  size is anticipated to reach USD 49.5 billion by 2030, according to the new report of Grand View Research, Inc. The market is expected to expand at a CAGR of 7.4% from 2022 to 2030. Omics has turned out to be the most advanced approach in molecular research. It includes all the field of biological sciences that ends with the suffix - omics. Various disciplines can be classified as omics such as proteomics, genomics, transcriptomics, and metabolomics. The outbreak of coronavirus accelerated the adoption of new approaches, models, and technology in clinical trials, this has positively impacted market growth. The outbreak of COVID-19 has caused havoc and has disrupted almost every sector of industry. Initially, the outbreak has negatively impacted the ecosystem of clinical trials and affected many ongoing studies for numerous indications. However, in the second half of 2020, researchers started developing innovative therapeutics and vaccine

  The global  nutraceuticals market  size is expected to reach USD 991.09 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 9.0% from 2021 to 2030. Rising awareness regarding calorie reduction and weight loss in the major markets including the U.S., China, and India is expected to promote the application of the health and wellness segment and thus, in turn, will have a substantial impact on the industry. Nutraceuticals are products that provide health advantages and additional nutrition to the human body. It comprises fortified nutrients, such as taurine, CoQ10, omega-3, calcium, zinc, and antioxidants, that develop the complete health of consumers. These nutrients further benefit in averting medical conditions such as hypertension, diabetes, heart diseases, and allergies. As nutraceuticals develop the digestive and immune systems and enhance the cognitive behavior of consumers, their demand is witnessing a surge at the global

  The global  clear aligners market  size is expected to reach USD 32.3 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 29.5% from 2022 to 2030. Clear aligners are invisible and discreet braces developed from thermoformed materials like copolyester or polycarbonate plastic and CAD 3D printing technology, acting as an alternative to traditional braces. According to the FDA, the clear aligner system helps in positioning the teeth through continuous gentle force and is developed to treat mild to moderate malocclusion. According to the WHO, malocclusion is the third most prevalent dental disease after dental caries and periodontal disease globally. Malocclusion of the teeth causes the problem of misalignment, which can later lead to severe oral health complications like hard and soft tissue trauma. This condition is hereditary and can be passed from one generation to another. Browse Full Report: https://www.grandviewresearch.com

 The global  animal based protein supplements market  size is expected to reach USD 22.26 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 7.4% from 2020 to 2028. Increasing instances of fitness and sporting activities among consumers have led to nutrition awareness, thus positively impacting the market growth. The whey raw material segment dominated the global market in 2020 owing to the availability of high protein content in it. Additionally, it is increasingly being used as a protein source for fortifying functional and nutritional food products, which is further expected to increase its demand during the forecast period. The protein powder product segment accounted for the largest revenue share in 2020. The escalating global trends of exercise and fitness, coupled with a strong preference among consumers for snacks that boost energy and aid in muscle building, are contributing to the growth of energy-building snacks such

  The global  cardiac rhythm management devices market  size is anticipated to reach USD 31.9 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a lucrative CAGR of 6.5% from 2022 to 2030. The key factors driving the market include growth in the adoption of cardiac rhythm management (CRM) devices owing to the increasing prevalence of cardiovascular disorders. According to the Centers for Disease Control and Prevention (CDC), as of September 2021, approximately 659,000 Americans die suffering from heart disease every year. The market was negatively impacted during the COVID-19 pandemic, as elective procedures, including the non-essential cardiovascular procedures, were postponed or canceled during the pandemic. Major players in the market such as Medtronic; Abbott; and Boston Scientific Corporation, incurred huge losses in their cardiac rhythm management business segments globally. This resulted in negative growth of the market in

 The global  veterinary telehealth market  size is expected to reach USD 546.8 million by 2030 according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 17.6% from 2022 to 2030. An increase in the adoption of telehealth services among pet owners coupled with the rising prevalence of animal diseases is a key contributor to market growth. The key advantages of veterinary telehealth such as saving transportation costs and reduction of ancillary expenses are driving the growth of the market. In addition, the doctor’s advice and virtual care can be obtained on an immediate basis. Further, it also saves time as animal caretakers can skip the time consumed during long waiting hours. Such factors are boosting market growth. There is increased adoption of IoT and AI by farmers and pet parents. This can be attributed to the increase in internet penetration and user-friendly animal healthcare websites or apps. Such factors are anticipated to increase the

  The global  virtual clinical trials market  size is expected to reach USD 12.9 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.7% from 2022 to 2030. The COVID-19 pandemic has significantly impacted the market. The growing need for patient diversity clubbed with enhanced data collection in clinical trials is boosting the market growth. There has been a rise in the R&D of new drugs and vaccines that has increased the volume and complexity of clinical trials. Virtual clinical trials eliminate challenges posed by traditional clinical trials for example delays in patient recruitment and time-consuming procedures. Also, studies have revealed that around 75.0% of people favored a mobile trial over traditional ones and 80.0% of patients are more likely to participate in a clinical trial that uses mobile technology. The market is recovering at a significant pace after the pandemic as it offers various benefits to pati

  The global  life science analytics market  size is expected to reach USD 16.3 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 7.7% from 2022 to 2030. The growing demand to enhance patient care experience and improve clinical outcomes while minimizing rising healthcare expenses is driving the adoption of analytical solutions in the life sciences market. Social media and improving internet connectivity are significantly impacting the demand for analytical solutions. Emerging trends of the digitalization of healthcare and the growing demand for personalized medicine are contributing to the adoption rates. Furthermore, the adoption of big data analytics and the emergence of advanced data mining techniques are bolstering market growth.  The ongoing Covid-19 pandemic exposed the shortcomings of the existing, overburdened healthcare systems, thus driving the demand for analytical solutions. Key players are rapidly making technolo

  The global  medical fiber optics market  size is expected to reach USD 1.6 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.0% from 2022 to 2030. The market growth can be credited to the advancements in healthcare infrastructure, readiness to adopt technologically advanced products, growing prevalence of cancer, and rising awareness regarding minimally invasive surgeries. The growing adoption of laser technology in various healthcare services and a surge in endoscopic procedures for diagnostic and therapeutic purposes are the key factors fueling the market growth. The growing trend of opting for minimally invasive surgeries over conventional open surgeries owing to the benefits associated with minimally invasive surgeries, such as reduced hospitalization, minimized infection risk, and quicker recovery periods is driving the demand for medical fiber optics. The ongoing COVID-19 pandemic burdened the healthcare systems resu

  The global  pacemakers market  size is anticipated to reach USD 5.94 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a lucrative CAGR of 3.4% from 2022 to 2030. This growth is owing to various factors such as technological advancements and the increasing prevalence of cardiovascular devices. Furthermore, the growing sedentary lifestyle coupled with the rising geriatric population is also anticipated to fuel the market growth during the projected period. During the COVID-19 pandemic, the market experienced a decline in revenues. This is owing to the postponement and cancellation of surgeries. According to the National Center for Biotechnology Information (NCBI), there was around a 73% reduction in de-novo pacemaker implantation during the initial months of the pandemic, which heavily impacted the market. The increasing prevalence of cardiovascular diseases is a key growth driver for the market. As per the CDC in 2017, CVDs ac

  The global  pharmacovigilance market  size is expected to reach USD 13.90 billion by 2030, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 9.3% from 2022 to 2030. The increasing incidence of Adverse Drug Reactions (ADR) is a key growth factor. ADR imposes a substantial burden on healthcare systems and is one of the prominent causes of morbidity in developed countries. According to the National Center for Biotechnology Information (NCBI), approximately 5% of total hospitalizations in Europe each year are due to ADR. Pharmacovigilance services play an integral role in this clinical trial phase by assisting manufacturers in identifying adverse effects associated with the drug. COVID-19 has undoubtedly thrown up numerous challenges as well as opportunities for pharmacovigilance service providers. Various companies are developing innovative platforms to gain a competitive edge. For instance, in December 2020, ArisGlobal and EVERSANA declared a